Regeneron pauses enrolment in trials of drug for lymphomas,

The move comes after the US Food and Drug Administration (FDA) put a partial clinical hold on the trials. The FDA sought amendments in trial protocols …, The move comes after the US Food and Drug Administration (FDA) put a partial clinical hold on the trials. The FDA sought amendments in trial protocols …, Read More

Scroll to Top